Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.07 – $0.17
79% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60.3M | $45.8M | $59.0M | $56.7M | $55.2M | $55.7M | $27.8M | $38.8M |
| Cost of revenue | $23.9M | $17.2M | $15.2M | $13.4M | $18.0M | $18.4M | $16.1M | $17.1M |
| Gross profit | $36.4M | $28.6M | $29.4M | $28.6M | $37.2M | $37.3M | $11.7M | $21.7M |
| Gross margin | 60.3% | 62.5% | 49.9% | 50.4% | 67.4% | 66.9% | 42.1% | 56.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$6.3M | −$2.7M | $7.0M | $6.4M | $4.2M | $2.7M | −$20.6M | −$15.1M |
| EBITDA | −$3.3M | $12.7M | $12.0M | $10.8M | $9.3M | $8.6M | −$14.4M | −$10.7M |
| Net income | $1.8M | $4.8M | $6.5M | $6.1M | $4.9M | $3.5M | −$18.7M | −$12.6M |
| Net margin | 2.9% | 10.5% | 11.1% | 10.8% | 8.9% | 6.3% | -67.1% | -32.5% |
| EPS (diluted) | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | -0.07 | -0.05 |
Annual figures · source: Financial Modeling Prep
CORDLIFE GROUP LTD ORD
No one on the platform currently holds CLIFF.
No tracked institution reports a position in CLIFF as of their last filing.
No one on the platform has traded CLIFF yet.
| $51M |
| — |
| FNCHFinch Therapeutics Group, Inc. | $8.70 | +16.00% | $14M | — |
| IPDQFImpediMed Limited | $0.01 | -1.96% | $10M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 1.2× sales vs its 1.2× historical median P/S.
Fair value ≈ $0.15 · price $0.15 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.